Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN FRANCISCO, Sept. 14, 2010 (GLOBE NEWSWIRE) -- YesDTC Holdings, Inc. (OTCBB:YESD), a direct-to-consumer global distributor and marketer of consumer goods and products, today announced the...
-
SCHOFIELD, Wis., Sept. 14, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCBB:PMBS) announced today that it is launching a print advertising campaign for its migraine medication LipiGesic™...
-
SEATTLE, Sept. 13, 2010 (GLOBE NEWSWIRE) -- U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced on Friday that nearly $20 million in new technical support assistance has...
-
MOUNTAIN VIEW, Calif., Sept. 13, 2010 (GLOBE NEWSWIRE) -- Conceptus Inc. (Nasdaq:CPTS), developer of the Essure(R) procedure, the most effective non-surgical permanent birth control method available,...
-
TEMPE, Ariz., Sept. 13, 2010 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) (the "Company") announced today that participating subjects have reached the planned twelve-month timepoint in the...
-
HONG KONG, Sept. 13, 2010 (GLOBE NEWSWIRE) -- The Board of Directors of Sinobiomed Inc. ("Sinobiomed", or "the Company") (Pink Sheets:SOBM) is pleased to announce that the Company's management,...
-
REDWOOD CITY, Calif., Sept. 13, 2010 (GLOBE NEWSWIRE) -- Informatica Corporation (Nasdaq:INFA), the world's number one independent provider of data integration software, today announced that Availity,...
-
ANDOVER, Mass., Sept. 13, 2010 (GLOBE NEWSWIRE) -- Dynamics Research Corporation (Nasdaq:DRCO), a leading provider of innovative management consulting, engineering, and technology solutions to federal...
-
ALACHUA, Fla. and CLEVELAND, Sept. 13, 2010 (GLOBE NEWSWIRE) -- RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, and Athersys Inc. (Athersys)...
-
SAN DIEGO, Sept. 13, 2010 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today the achievement of key efficacy, immunogenicity and safety results in a Phase 2 trial, establishing its...